Treosulfan is a substance that is being studied in the treatment of cancer. It belongs to the family of drugs called alkylating agents. Its has been used mainly as a substitute of busulfan in frail patients as the side effects and toxicity are supposedly less severe.
This page contains content from the copyrighted Wikipedia article "Treosulfan"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
